Report Detail
Global Colorectal Cancer Molecular Diagnostics Supply, Demand and Key Producers, 2026-2032
- RnM4663751 |
- 19 January, 2026 |
- Global |
- 102 Pages |
- GIR |
- Medical Devices & Consumables
The global Colorectal Cancer Molecular Diagnostics market size is expected to reach $ 2195 million by 2032, rising at a market growth of 13.8% CAGR during the forecast period (2026-2032).
Colorectal Cancer Molecular Diagnostics refers to the use of molecular techniques to detect specific genetic mutations, biomarkers, and molecular alterations associated with colorectal cancer. These diagnostics help in identifying cancer subtypes, predicting the patient's response to treatment, and assessing the risk of cancer recurrence. Methods used in molecular diagnostics include polymerase chain reaction (PCR), next-generation sequencing (NGS), and fluorescence in situ hybridization (FISH), among others. By providing personalized information about the tumor’s genetic profile, molecular diagnostics enable targeted therapies and improve the precision of treatment plans for colorectal cancer patients.
Colorectal Cancer Molecular Diagnostics Market Drivers:
Rising Prevalence of Colorectal Cancer: As colorectal cancer remains one of the most common cancers globally, the growing number of cases is a key driver for the molecular diagnostics market. Early detection and personalized treatment approaches are increasingly in demand.
Advancements in Molecular Diagnostics Technology: Innovations like next-generation sequencing (NGS), liquid biopsy, and biomarker discovery have improved the accuracy and efficiency of diagnostics, making them more accessible and appealing to healthcare providers and patients.
Personalized Medicine and Targeted Therapies: The shift toward personalized treatment in oncology, where therapies are tailored based on the patient’s genetic profile, is driving the adoption of molecular diagnostics to identify specific mutations and biomarkers in colorectal cancer.
Increasing Awareness and Screening Programs: Governments and health organizations are promoting regular colorectal cancer screenings, driving the demand for advanced diagnostic tests.
Colorectal Cancer Molecular Diagnostics Market Challenges:
High Costs and Reimbursement Issues: Advanced molecular diagnostics can be expensive, and the lack of consistent reimbursement policies across different regions limits their widespread adoption, particularly in low- and middle-income countries.
Complexity of Genetic Data Interpretation: As molecular diagnostics provide a vast amount of genetic data, interpreting these results requires specialized expertise. This can create a barrier in regions where access to highly skilled professionals is limited.
Regulatory Hurdles: Stringent regulations surrounding the approval and clinical use of molecular diagnostics can slow down market growth, especially when it comes to introducing new and innovative tests.
Limited Awareness in Developing Regions: While awareness of colorectal cancer and molecular diagnostics is growing in developed countries, many developing regions still face challenges related to lack of awareness and infrastructure for advanced diagnostic techniques.
Global core colorectal cancer molecular diagnostics players include Roche Diagnostics, Abbott and Thermo Fisher etc. The top 3 companies hold a share about 45%. North America is the largest market with a share about 43%, followed by Asia-Pacific and Europe.
This report studies the global Colorectal Cancer Molecular Diagnostics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Colorectal Cancer Molecular Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Colorectal Cancer Molecular Diagnostics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Colorectal Cancer Molecular Diagnostics total market, 2021-2032, (USD Million)
Global Colorectal Cancer Molecular Diagnostics total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Colorectal Cancer Molecular Diagnostics total market, key domestic companies, and share, (USD Million)
Global Colorectal Cancer Molecular Diagnostics revenue by player, revenue and market share 2021-2026, (USD Million)
Global Colorectal Cancer Molecular Diagnostics total market by Type, CAGR, 2021-2032, (USD Million)
Global Colorectal Cancer Molecular Diagnostics total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Colorectal Cancer Molecular Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Biomerieux, Bio-Rad, Agilent, Daangene, Amoydx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Colorectal Cancer Molecular Diagnostics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Colorectal Cancer Molecular Diagnostics Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Colorectal Cancer Molecular Diagnostics Market, Segmentation by Type:
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Global Colorectal Cancer Molecular Diagnostics Market, Segmentation by Application:
Hospital
Third-Party Testing Agency
Others
Companies Profiled:
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx
Key Questions Answered
1. How big is the global Colorectal Cancer Molecular Diagnostics market?
2. What is the demand of the global Colorectal Cancer Molecular Diagnostics market?
3. What is the year over year growth of the global Colorectal Cancer Molecular Diagnostics market?
4. What is the total value of the global Colorectal Cancer Molecular Diagnostics market?
5. Who are the Major Players in the global Colorectal Cancer Molecular Diagnostics market?
6. What are the growth factors driving the market demand?
1 Supply Summary
- 1.1 Colorectal Cancer Molecular Diagnostics Introduction
- 1.2 World Colorectal Cancer Molecular Diagnostics Market Size & Forecast (2021 & 2025 & 2032)
- 1.3 World Colorectal Cancer Molecular Diagnostics Total Market by Region (by Headquarter Location)
- 1.3.1 World Colorectal Cancer Molecular Diagnostics Market Size by Region (2021-2032), (by Headquarter Location)
- 1.3.2 United States Based Company Colorectal Cancer Molecular Diagnostics Revenue (2021-2032)
- 1.3.3 China Based Company Colorectal Cancer Molecular Diagnostics Revenue (2021-2032)
- 1.3.4 Europe Based Company Colorectal Cancer Molecular Diagnostics Revenue (2021-2032)
- 1.3.5 Japan Based Company Colorectal Cancer Molecular Diagnostics Revenue (2021-2032)
- 1.3.6 South Korea Based Company Colorectal Cancer Molecular Diagnostics Revenue (2021-2032)
- 1.3.7 ASEAN Based Company Colorectal Cancer Molecular Diagnostics Revenue (2021-2032)
- 1.3.8 India Based Company Colorectal Cancer Molecular Diagnostics Revenue (2021-2032)
- 1.4 Market Drivers, Restraints and Trends
- 1.4.1 Colorectal Cancer Molecular Diagnostics Market Drivers
- 1.4.2 Factors Affecting Demand
- 1.4.3 Major Market Trends
2 Demand Summary
- 2.1 World Colorectal Cancer Molecular Diagnostics Consumption Value (2021-2032)
- 2.2 World Colorectal Cancer Molecular Diagnostics Consumption Value by Region
- 2.2.1 World Colorectal Cancer Molecular Diagnostics Consumption Value by Region (2021-2026)
- 2.2.2 World Colorectal Cancer Molecular Diagnostics Consumption Value Forecast by Region (2027-2032)
- 2.3 United States Colorectal Cancer Molecular Diagnostics Consumption Value (2021-2032)
- 2.4 China Colorectal Cancer Molecular Diagnostics Consumption Value (2021-2032)
- 2.5 Europe Colorectal Cancer Molecular Diagnostics Consumption Value (2021-2032)
- 2.6 Japan Colorectal Cancer Molecular Diagnostics Consumption Value (2021-2032)
- 2.7 South Korea Colorectal Cancer Molecular Diagnostics Consumption Value (2021-2032)
- 2.8 ASEAN Colorectal Cancer Molecular Diagnostics Consumption Value (2021-2032)
- 2.9 India Colorectal Cancer Molecular Diagnostics Consumption Value (2021-2032)
3 World Colorectal Cancer Molecular Diagnostics Companies Competitive Analysis
- 3.1 World Colorectal Cancer Molecular Diagnostics Revenue by Player (2021-2026)
- 3.2 Industry Rank and Concentration Rate (CR)
- 3.2.1 Global Colorectal Cancer Molecular Diagnostics Industry Rank of Major Players
- 3.2.2 Global Concentration Ratios (CR4) for Colorectal Cancer Molecular Diagnostics in 2025
- 3.2.3 Global Concentration Ratios (CR8) for Colorectal Cancer Molecular Diagnostics in 2025
- 3.3 Colorectal Cancer Molecular Diagnostics Company Evaluation Quadrant
- 3.4 Colorectal Cancer Molecular Diagnostics Market: Overall Company Footprint Analysis
- 3.4.1 Colorectal Cancer Molecular Diagnostics Market: Region Footprint
- 3.4.2 Colorectal Cancer Molecular Diagnostics Market: Company Product Type Footprint
- 3.4.3 Colorectal Cancer Molecular Diagnostics Market: Company Product Application Footprint
- 3.5 Competitive Environment
- 3.5.1 Historical Structure of the Industry
- 3.5.2 Barriers of Market Entry
- 3.5.3 Factors of Competition
- 3.6 Mergers & Acquisitions Activity
4 United States VS China VS Rest of World (by Headquarter Location)
- 4.1 United States VS China: Colorectal Cancer Molecular Diagnostics Revenue Comparison (by Headquarter Location)
- 4.1.1 United States VS China: Colorectal Cancer Molecular Diagnostics Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
- 4.1.2 United States VS China: Colorectal Cancer Molecular Diagnostics Revenue Market Share Comparison (2021 & 2025 & 2032)
- 4.2 United States Based Companies VS China Based Companies: Colorectal Cancer Molecular Diagnostics Consumption Value Comparison
- 4.2.1 United States VS China: Colorectal Cancer Molecular Diagnostics Consumption Value Comparison (2021 & 2025 & 2032)
- 4.2.2 United States VS China: Colorectal Cancer Molecular Diagnostics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
- 4.3 United States Based Colorectal Cancer Molecular Diagnostics Companies and Market Share, 2021-2026
- 4.3.1 United States Based Colorectal Cancer Molecular Diagnostics Companies, Headquarters (States, Country)
- 4.3.2 United States Based Companies Colorectal Cancer Molecular Diagnostics Revenue, (2021-2026)
- 4.4 China Based Companies Colorectal Cancer Molecular Diagnostics Revenue and Market Share, 2021-2026
- 4.4.1 China Based Colorectal Cancer Molecular Diagnostics Companies, Company Headquarters (Province, Country)
- 4.4.2 China Based Companies Colorectal Cancer Molecular Diagnostics Revenue, (2021-2026)
- 4.5 Rest of World Based Colorectal Cancer Molecular Diagnostics Companies and Market Share, 2021-2026
- 4.5.1 Rest of World Based Colorectal Cancer Molecular Diagnostics Companies, Headquarters (Province, Country)
- 4.5.2 Rest of World Based Companies Colorectal Cancer Molecular Diagnostics Revenue (2021-2026)
5 Market Analysis by Type
- 5.1 World Colorectal Cancer Molecular Diagnostics Market Size Overview by Type: 2021 VS 2025 VS 2032
- 5.2 Segment Introduction by Type
- 5.2.1 Polymerase Chain Reaction PCR
- 5.2.2 Molecular Hybridization
- 5.2.3 Biochip
- 5.2.4 Others
- 5.3 Market Segment by Type
- 5.3.1 World Colorectal Cancer Molecular Diagnostics Market Size by Type (2021-2026)
- 5.3.2 World Colorectal Cancer Molecular Diagnostics Market Size by Type (2027-2032)
- 5.3.3 World Colorectal Cancer Molecular Diagnostics Market Size Market Share by Type (2027-2032)
6 Market Analysis by Application
- 6.1 World Colorectal Cancer Molecular Diagnostics Market Size Overview by Application: 2021 VS 2025 VS 2032
- 6.2 Segment Introduction by Application
- 6.2.1 Hospital
- 6.2.2 Third-Party Testing Agency
- 6.2.3 Others
- 6.3 Market Segment by Application
- 6.3.1 World Colorectal Cancer Molecular Diagnostics Market Size by Application (2021-2026)
- 6.3.2 World Colorectal Cancer Molecular Diagnostics Market Size by Application (2027-2032)
- 6.3.3 World Colorectal Cancer Molecular Diagnostics Market Size Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Roche Diagnostics
- 7.1.1 Roche Diagnostics Details
- 7.1.2 Roche Diagnostics Major Business
- 7.1.3 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product and Services
- 7.1.4 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
- 7.1.5 Roche Diagnostics Recent Developments/Updates
- 7.1.6 Roche Diagnostics Competitive Strengths & Weaknesses
- 7.2 Abbott
- 7.2.1 Abbott Details
- 7.2.2 Abbott Major Business
- 7.2.3 Abbott Colorectal Cancer Molecular Diagnostics Product and Services
- 7.2.4 Abbott Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
- 7.2.5 Abbott Recent Developments/Updates
- 7.2.6 Abbott Competitive Strengths & Weaknesses
- 7.3 Thermo Fisher
- 7.3.1 Thermo Fisher Details
- 7.3.2 Thermo Fisher Major Business
- 7.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Product and Services
- 7.3.4 Thermo Fisher Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
- 7.3.5 Thermo Fisher Recent Developments/Updates
- 7.3.6 Thermo Fisher Competitive Strengths & Weaknesses
- 7.4 Qiagen
- 7.4.1 Qiagen Details
- 7.4.2 Qiagen Major Business
- 7.4.3 Qiagen Colorectal Cancer Molecular Diagnostics Product and Services
- 7.4.4 Qiagen Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
- 7.4.5 Qiagen Recent Developments/Updates
- 7.4.6 Qiagen Competitive Strengths & Weaknesses
- 7.5 Illumina
- 7.5.1 Illumina Details
- 7.5.2 Illumina Major Business
- 7.5.3 Illumina Colorectal Cancer Molecular Diagnostics Product and Services
- 7.5.4 Illumina Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
- 7.5.5 Illumina Recent Developments/Updates
- 7.5.6 Illumina Competitive Strengths & Weaknesses
- 7.6 Biomerieux
- 7.6.1 Biomerieux Details
- 7.6.2 Biomerieux Major Business
- 7.6.3 Biomerieux Colorectal Cancer Molecular Diagnostics Product and Services
- 7.6.4 Biomerieux Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
- 7.6.5 Biomerieux Recent Developments/Updates
- 7.6.6 Biomerieux Competitive Strengths & Weaknesses
- 7.7 Bio-Rad
- 7.7.1 Bio-Rad Details
- 7.7.2 Bio-Rad Major Business
- 7.7.3 Bio-Rad Colorectal Cancer Molecular Diagnostics Product and Services
- 7.7.4 Bio-Rad Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
- 7.7.5 Bio-Rad Recent Developments/Updates
- 7.7.6 Bio-Rad Competitive Strengths & Weaknesses
- 7.8 Agilent
- 7.8.1 Agilent Details
- 7.8.2 Agilent Major Business
- 7.8.3 Agilent Colorectal Cancer Molecular Diagnostics Product and Services
- 7.8.4 Agilent Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
- 7.8.5 Agilent Recent Developments/Updates
- 7.8.6 Agilent Competitive Strengths & Weaknesses
- 7.9 Daangene
- 7.9.1 Daangene Details
- 7.9.2 Daangene Major Business
- 7.9.3 Daangene Colorectal Cancer Molecular Diagnostics Product and Services
- 7.9.4 Daangene Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
- 7.9.5 Daangene Recent Developments/Updates
- 7.9.6 Daangene Competitive Strengths & Weaknesses
- 7.10 Amoydx
- 7.10.1 Amoydx Details
- 7.10.2 Amoydx Major Business
- 7.10.3 Amoydx Colorectal Cancer Molecular Diagnostics Product and Services
- 7.10.4 Amoydx Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
- 7.10.5 Amoydx Recent Developments/Updates
- 7.10.6 Amoydx Competitive Strengths & Weaknesses
8 Industry Chain Analysis
- 8.1 Colorectal Cancer Molecular Diagnostics Industry Chain
- 8.2 Colorectal Cancer Molecular Diagnostics Upstream Analysis
- 8.3 Colorectal Cancer Molecular Diagnostics Midstream Analysis
- 8.4 Colorectal Cancer Molecular Diagnostics Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
- 10.1 Methodology
- 10.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Colorectal Cancer Molecular Diagnostics. Industry analysis & Market Report on Colorectal Cancer Molecular Diagnostics is a syndicated market report, published as Global Colorectal Cancer Molecular Diagnostics Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Colorectal Cancer Molecular Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
